Literature DB >> 16965507

Resolution of subretinal haemorrhage and fluid after intravitreal bevacizumab in aggressive peripapillary subretinal neovascularization.

Wael Soliman1, Henrik Lund-Andersen, Michael Larsen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16965507     DOI: 10.1111/j.1600-0420.2006.00736.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN: 1395-3907


× No keyword cloud information.
  5 in total

1.  [Combined intravitreal injection of bevacizumab and SF6 gas for treatment of submacular hemorrhage secondary to age-related macular degeneration].

Authors:  F Höhn; A Mirshahi; L-O Hattenbach
Journal:  Ophthalmologe       Date:  2010-04       Impact factor: 1.059

2.  Intravitreal bevacizumab: an analysis of the evidence.

Authors:  Derrick P Smit; David Meyer
Journal:  Clin Ophthalmol       Date:  2007-09

3.  Displacement of submacular hemorrhage associated with age-related macular degeneration using vitrectomy and submacular tPA injection followed by intravitreal ranibizumab.

Authors:  Sukhpal Singh Sandhu; Sridhar Manvikar; David Henry William Steel
Journal:  Clin Ophthalmol       Date:  2010-07-21

4.  Effect of intravitreal ranibizumab in the treatment of peripapillary choroidal neovascularisation.

Authors:  Hassan Hamoudi; Torben Lykke Sørensen
Journal:  J Ophthalmol       Date:  2011-12-22       Impact factor: 1.909

5.  Comparison of treatment methods for submacular hemorrhage in neovascular age-related macular degeneration: conservative versus active surgical strategy.

Authors:  Yongseok Mun; Kyu Hyung Park; Sang Jun Park; Han Joo Cho; Chul Gu Kim; Jong Woo Kim; Dong Geun Park; Min Sagong; Jae Hui Kim; Se Joon Woo
Journal:  Sci Rep       Date:  2022-09-01       Impact factor: 4.996

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.